Neurogene NGNE
NASDAQ NGNE
$25.41 +0.13 (+0.51%)
As of: Nov 11, 2026 · 1:07 PM EST

Neurogene (NGNE) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Neurogene's Depreciation & Amortization (CF) was $813,000 in Q2 2026, up 1.6% from $800,000 a year earlier but down 4.0% from the prior quarter.

Analysis

Neurogene (NGNE) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Neurogene's Depreciation & Amortization (CF) was $3.2 million through Jun 30, 2026, up 2.0% year-over-year; for FY2025, it came in at $3.04 million, down 4.9% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 31.1% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $3.2 million in FY2024 (-3.0%), $3.3 million in FY2023 (+3.1%), $3.2 million in FY2022 (+145.0%) and $1.31 million in FY2021 (+66.4%).
  • Quarterly Depreciation & Amortization (CF) has moved between $323,000 (Q3 2022) and $2.01 million (Q4 2022) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in two of the last eight quarters, with an average decline of 0.9%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2022 (growth of 414.6%); the worst was Q4 2023 (a decline of 57.4%).
  • Per Business Quant data, NGNE's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $847,000 (Q1 2026), $743,000 (Q4 2025) and $800,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Neurogene 700.15 Mn -397.16 Mn - 821,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 821,000.00
Jun 30, 2026 813,000.00
Mar 31, 2026 847,000.00
Dec 31, 2025 776,000.00
Sep 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 749,000.00
Dec 31, 2024 790,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 814,000.00
Dec 31, 2023 855,000.00
Sep 30, 2023 800,000.00
Jun 30, 2023 800,000.00
Mar 31, 2023 812,000.00
Dec 31, 2022 2.01 Mn
Sep 30, 2022 323,000.00
Jun 30, 2022 459,000.00
Mar 31, 2022 411,000.00
Dec 31, 2021 390,000.00
API Access

Neurogene Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NGNE&period=max&api_key=YOUR_API_KEY